(Q46633267)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

title

Efficacy and safety in sitagliptin therapy for diabetes complicated by non-alcoholic fatty liver disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference

ChEBI release 2020-05-28

ChEBI ID

40237

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Tetsuya Hosaka

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

13

Hiromitsu Kumada

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

5

Fumitaka Suzuki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

12

Kenji Ikeda

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

8

Masahiro Kobayashi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

6

Yoshiyuki Suzuki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

7

Norio Akuta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1

Yasuji Arase

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

9

Hitomi Sezaki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

2

Yusuke Kawamura

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

4

Mariko Kobayashi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

10

Satoshi Saito

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

author name string

Yuya Seko

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Yuki Ohmoto-Sekine

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Shiun Dong Hsieh

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Kazuhisa Amakawa

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Kyoko Ogawa

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Naoki Matsumoto

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Akiko Iwao

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Hiroshi Tsuji

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Shigeko Hara

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Yasumichi Mori

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Minoru Okubo

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Tetsuro Kobayashi

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

publication date

12 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

page(s)

1163-1168

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

Nonalcoholic fatty liver disease

25 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12077

Global challenges in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12077

Diagnosis and therapy of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12077

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12077

Epidemiology of non-alcoholic fatty liver disease in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12077

Liver diseases and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12077

Prevalence, gender, ethnic variations, and prognosis of NASH

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12077

Visceral fat: a key mediator of steatohepatitis in metabolic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12077

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12077

Identification of individuals with insulin resistance using routine clinical measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12077

Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12077

Elevated serum aminotransferase levels in children at risk for obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12077

The development of chronic kidney disease in Japanese patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12077

Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12077

Postprandial insulin secretion pattern is associated with histological severity in non-alcoholic fatty liver disease patients without prior known diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12077

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12077

Metabolism and excretion of the dipeptidyl peptidase 4 inhibitor [14C]sitagliptin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12077

Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12077

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12077

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12077

Efficacy and safety in sitagliptin therapy for diabetes complicated by chronic liver disease caused by hepatitis C virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12077

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12077

21 January 2018

Identifiers

DOI

10.1111/HEPR.12077

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23489256%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference